Costly Cancer Drug Offers Hope, but Also a Dilemma

Home > Rss Directory > Business > NY Time > Costly Cancer Drug Offers Hope, but Also a Dilemma

Costly Cancer Drug Offers Hope, but Also a Dilemma more»»
Avastin, which can cost as much as $100,000 a year, has become one of the most popular cancer drugs, but studies show it prolongs life by only a few months.

Sun Jul 06, 2008

Home > Rss Directory > Business > NY Time


Sponsored Links

Rss - Latest News

Mitsubishi and Morgan Stanley Renegotiating more»»
Mitsubishi was pressing for more favorable terms on Sunday after Morgan Stanley lost nearly half its market value during last week’s stock market plunge.

Protectionist Policies Won’t Solve Crisis, Paulson Says more»»
Appealing for global unity in a time of crisis, Treasury Secretary Henry M. Paulson Jr. said Sunday that isolationism and protectionism do not offer a way to contain the spreading damage.

European Leaders Agree to Inject Cash Into Banks more»»
European countries, led by Germany and France, pledged to take equity stakes in distressed banks and to guarantee lending for periods up to five years.

Study Warns of Hearing Loss From Music Players more»»
A scientific study for the European Union found that listening to personal music players at high volume can threaten permanent hearing loss.

Those With a Sense of History May Find It’s Time to Invest more»»
Some investors say that the sell-off has gone too far and that stocks could stage a powerful rally.